Teleflex Incorporated
$131.95
▼
-0.52%
2026-04-21 09:47:01
www.teleflex.com
NYQ: TFX
Explore Teleflex Incorporated stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$5.84 B
Current Price
$131.95
52W High / Low
$138.93 / $100.18
Stock P/E
—
Book Value
$70.7
Dividend Yield
1.03%
ROCE
4.14%
ROE
1.58%
Face Value
—
EPS
$1.31
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
15,500
Beta
0.83
Debt / Equity
90.32
Current Ratio
2.54
Quick Ratio
2.01
Forward P/E
11.68
Price / Sales
2.63
Enterprise Value
$7.65 B
EV / EBITDA
16.31
EV / Revenue
3.84
Rating
Hold
Target Price
$130.22
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Utah Medical Products, Inc. | $70.22 | 20.02 | $225.9 M | 1.77% | 9.51% | 9.54% | $71.81 / $51.26 | $37.43 |
| 2. | Retractable Technologies, Inc. | $0.65 | — | $19.46 M | 1.18% | -10.73% | -15.56% | $1.14 / $0.62 | $2.48 |
| 3. | NEXGEL, Inc. | $0.64 | — | $6.98 M | — | -41.75% | -52.74% | $2.99 / $0.56 | $0.64 |
| 4. | Cuprina Holdings (Cayman) Limited | $0.33 | — | $2.47 M | — | 34.48% | -1.39% | $9.5 / $0.28 | $0.28 |
| 5. | Kestra Medical Technologies, Ltd. | $23.31 | — | $1.33 B | — | -41.27% | -92.65% | $30 / $13.25 | $4.94 |
| 6. | Warby Parker Inc. | $25.89 | 1,889.51 | $3.1 B | — | -0.93% | 0.46% | $31 / $13.63 | $3 |
| 7. | Stereotaxis, Inc. | $1.98 | — | $192.55 M | — | -73.98% | -1.44% | $3.59 / $1.74 | $0.14 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | -401.87 M | 913.02 M | 780.89 M | 700.67 M | 795.41 M | — |
| Operating Profit | -164.65 M | 112.65 M | 177.48 M | 130.32 M | 140.81 M | — |
| Net Profit | -714.33 M | -408.89 M | 122.58 M | 95 M | -136.66 M | — |
| EPS in Rs | -16.16 | -9.25 | 2.77 | 2.15 | -3.09 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.99 B | 1.7 B | 1.71 B | 2.79 B |
| Operating Profit | 255.8 M | 253.85 M | 303.75 M | 513.52 M |
| Net Profit | -905.64 M | 69.67 M | 356.33 M | 363.14 M |
| EPS in Rs | -20.49 | 1.58 | 8.06 | 8.22 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 6.95 B | 7.1 B | 7.53 B | 6.93 B |
| Total Liabilities | 3.82 B | 2.82 B | 3.09 B | 2.91 B |
| Equity | 3.12 B | 4.28 B | 4.44 B | 4.02 B |
| Current Assets | 1.94 B | 1.47 B | 1.41 B | 1.41 B |
| Current Liabilities | 762.03 M | 649.36 M | 606.75 M | 581.49 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 340.68 M | 635.74 M | 510.64 M | 342.14 M |
| Investing CF | -849.19 M | -99.36 M | -621.23 M | -257.94 M |
| Financing CF | 611.54 M | -421.93 M | 38.54 M | -217.51 M |
| Free CF | 245.44 M | 545.3 M | 464.22 M | 262.95 M |
| Capex | -95.24 M | -90.44 M | -46.42 M | -79.19 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -0.75% | -38.65% | — | — |
| Earnings Growth % | -80.45% | -1.88% | — | — |
| Profit Margin % | 4.1% | 20.81% | 13.01% | — |
| Operating Margin % | 14.94% | 17.74% | 18.4% | — |
| Gross Margin % | 61.04% | 60.74% | 54.86% | — |
| EBITDA Margin % | 15.97% | 24.44% | 26.18% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-06 | $0.34 |
| 2025-11-14 | $0.34 |
| 2025-08-15 | $0.34 |
| 2025-05-20 | $0.34 |
| 2025-03-07 | $0.34 |
Stock Splits
No stock split history available.